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Background: Two mitochondrial DNA clades have been described in Anopheles funestus populations from southern
Africa. Clade I is common across the continent while clade II is known only from Mozambique and Madagascar. The
specific biological status of these clades is at present unknown. We investigated the possible role that each clade
might play in the transmission of Plasmodium falciparum and the insecticide resistance status of An. funestus from
Zimbabwe and Zambia.
Methods: Mosquitoes were collected inside houses from Nchelenge District, Zambia and Honde Valley,
Zimbabwe in 2013 and 2014. WHO susceptibility tests, synergist assays and resistance intensity tests were
conducted on wild females and progeny of wild females. ELISA was used to detect Plasmodium falciparum
circumsporozoite protein. Specimens were identified to species and mtDNA clades using standard molecular
methods.
Results: The Zimbabwean samples were all clade I while the Zambian population comprised 80% clade I and 20%
clade II in both years of collection. ELISA tests gave an overall infection rate of 2.3% and 2.1% in 2013, and 3.5% and
9.2% in 2014 for Zimbabwe and Zambia respectively. No significant difference was observed between the clades. All
populations were resistant to pyrethroids and carbamates but susceptible to organochlorines and organophosphates.
Synergist assays indicated that pyrethroid resistance is mediated by cytochrome P450 mono-oxygenases. Resistance
intensity tests showed high survival rates after 8-hrs continuous exposure to pyrethroids but exposure to bendiocarb
gave the same results as the susceptible control.
Conclusions: This is the first record of An. funestus mtDNA clade II occurring in Zambia. No evidence was found
to suggest that the clades are markers of biologically separate populations. The ability of An. funestus to
withstand prolonged exposure to pyrethroids has serious implications for the use of these insecticides, either
through LLINs or IRS, in southern Africa in general and resistance management strategies should be urgently
implemented.
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In the recent past, malaria vector control has been primar-
ily pyrethroid-based through indoor residual house spray-
ing [IRS] or the use of long-lasting insecticide-treated bed
nets (LLINs) or both. This intensive use of insecticides, to-
gether with pesticide usage in agriculture, has led to a dra-
matic increase in resistance in the mosquito vectors across
the whole African continent [http://www.irmapper.com].
Anopheles funestus, one of the four major vectors of Plas-
modium falciparum malaria in Africa [1,2], is widely dis-
tributed throughout much of the African tropics and
subtropics [3]. The earliest records of insecticide resistance
in An. funestus are from the 1980s [4] and currently resist-
ance in this species is known from Mali, Guinea, Ghana,
Benin, Uganda, Kenya, Malawi, Zambia, Mozambique and
South Africa [1]. A well-documented impact of insecticide
resistance on vector control programme failure is the
major malaria epidemic that occurred in South Africa in
1999/2000 when pyrethroid resistant An. funestus returned
to South Africa after DDT was replaced with pyrethroids
for indoor house spraying [5]. The situation returned to
pre-failure levels after DDT was reintroduced and used in
a mosaic system together with pyrethroids. A number of
insecticide resistance studies on An. funestus from south-
ern Africa have been documented, but studies from other
regions are limited [1].
Anopheles funestus belongs to a group of at least 11
species, all of which are morphologically similar at the
adult stage [6,7]. Some members of the group can be dis-
tinguished on egg and larval characteristics (An. confusus,
An. rivulorum and An. leesoni) but this is not always the
case and those species belonging to the An. funestus sub-
group (An. funestus, An. funestus-like, An. parensis, An.
aruni and An. vaneedeni) are virtually identical [1,6,7]. The
importance of species identification lies in the fact that of
the 11 species, only An. funestus plays a major role in mal-
aria transmission, this species being highly adapted to
humans and human habitation with parasite infection rates
sometimes as high as 22% [6]. The only other member of
the group that has been implicated in low-level, localised
transmission is An. rivulorum in Tanzania [8] and western
Kenya [9] but in each case the parasite infection rates have
been below 1%.
Malaria vector control programmes need to know that
their interventions are targeting the major vectors so
that scarce resources are not wasted on non-vector mos-
quitoes. As a result, various genetical techniques have
been applied to members of the An. funestus group with
the aim of providing accurate species identification. Ini-
tially, the banding patterns of the giant polytene chromo-
somes were used [10,11] but these have limited practical
value because An. funestus and An. vaneedeni share the
same inversion arrangements resulting in the same band-
ing patterns [10], as do An. funestus and An. funestus-like[12]. In addition, the technique has the disadvantage of
being applicable only to half-gravid female mosquitoes.
However, studies of the chromosomal inversion polymor-
phisms in Burkina Faso revealed the existence of two dis-
tinct forms that apparently do not mate in sympatry [13]
and that are also significantly differentiated at the molecu-
lar level [14], supporting the hypothesis of two distinct
species being present. Twenty years after the work of
Green and Hunt [10,11], a molecular assay was developed
that allowed for the rapid and accurate identification of
the five most common members of the An. funestus group
[15] and this is the standard protocol used in many la-
boratories today.
While An. funestus has abundant levels of molecular and
chromosomal polymorphism across its range, there are
only a few population genetic studies of the species and
these are limited in geographic scope compared with simi-
lar work on the Anopheles gambiae complex [1]. Phylogen-
etic studies using mitochondrial DNA (mtDNA) have
revealed that there are two clades within An. funestus.
Clade I is widespread throughout the continent and
clade II is known only from southern Mozambique and
Madagascar [16,17]. It is estimated that these two
clades evolved independently about 1 million years ago
based on fixed differences and divergence in mtDNA
[16]. However, the deep mtDNA divergence was not
accompanied by corresponding nuclear divergence as
measured by 10 microsatellite loci in the same study
[16] so it is not clear what this genetic variation means
in terms of species differentiation.
In the present study, we investigated the biological at-
tributes of insecticide resistance and parasite infection
rates that both impact on malaria vector control activ-




Anopheles funestus specimens were collected resting in-
side houses from Honde Valley, Zimbabwe [18° 23.161′S,
32° 59.946′E] and Nchelenge District, Zambia [9° 19.115′S,
28° 45.070′E]. Permission to enter houses was obtained
from the village headmen and from each individual house
owner. Collections were carried out between February and
April 2013. In February and March 2014, the most pro-
ductive houses identified from the 2013 survey, were vis-
ited with the intention of maximizing the sample size over
the few days that were available for collecting.
Insecticide susceptibility tests
The WHO insecticide resistance tests [18] were per-
formed in the field (Zambia both years; Zimbabwe 2013
only, 2014 tests were carried out on F-1 progeny) to in-
vestigate the susceptibility status of wild-caught An.
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(0.05% deltamethrin and 0.05% lambda-cyhalothrin), carba-
mates (0.1% bendiocarb and 0.1% propoxur), organochlo-
rines (4.0% DDT and 4.0% dieldrin) and organophosphates
(5.0% malathion, 1.0% fenitrothion and 0.25% pirimiphos-
methyl). The age of the mosquitoes used for the tests was
unknown and the physiological status ranged from blood
fed to gravid. Each exposure consisted of ~25 randomly se-
lected mosquitoes for the seven insecticides plus controls.
Exposure time for six of the insecticides was 1 hour while
mosquitoes were exposed to fenitrothion for 2 hours [18].
The total number of mosquitoes exposed to each insecti-
cide was dependent on the numbers of mosquitoes avail-
able in the field and the initial results obtained for each
insecticide. Final mortality was recorded 24 hours post-
exposure. Efficacy of WHO insecticide papers was con-
firmed before and after the field tests using a known
susceptible mosquito strain (FANG - An. funestus origin-
ating from Angola and colonised in 2003). All exposed
specimens were stored on silica gel and returned to the
laboratory for further processing.
A proportion of the collection from both localities was
brought back to the laboratory alive. In the insectary, the
wild females were set up for egg-laying in small glass
vials lined with oval pieces of filter paper with a small
amount of water in the bottom [9,19] (Figure 1) and
held in wooden racks. This method usually results in
>70% of wild females laying eggs. The Zimbabwe collec-
tions yielded 92 egg batches in 2013 and 140 in 2014.
The Zambia collections yielded 148 clade I and 40 clade
II egg batches in 2013, and 265 clade I and 67 clade II in
2014. Egg batches were reared individually until species/
clade identification was obtained, at which point they
were pooled into their separate groups. First generationFigure 1 A very simple method for inducing egg-laying in wild Anoph
ovipositing. Glass vials, 45 mm high x 25 mm diameter, with gauze lids ar
bottom of the tube with approximately 1 ml water for egg laying. Females
they have laid eggs, facilitating blood-feeding for multiple egg batches.adults, aged 2–5 days, were used for synergist and re-
sistance intensity assays and, in the case of the 2014
Zimbabwe collections, also for WHO susceptibility tests.
Resistance intensity assays
Female Zimbabwe and Zambia samples were exposed to
0.05% deltamethrin, 0.1% bendiocarb and 0.05% lambda-
cyhalothrin (Zimbabwe samples only) treated papers con-
tinuously for 8 hours with knockdown being recorded at
various time intervals. The WHO test tubes were laid flat
so that once knocked down, the mosquitoes continued to
be exposed to the insecticide. The 8-hr cut-off was arbi-
trarily chosen as the likely time a mosquito might come
into contact with a sprayed wall after taking a blood meal.
The susceptible laboratory strain FANG was used as a
control.
Synergist bioassays
Synergist assays [20] were performed by exposing 153
clade I specimens from Zimbabwe, 128 clade I and 113
clade II specimens from Zambia to 4% piperonyl butox-
ide (PBO), an inhibitor of monooxygenases, for 1 h prior
to exposing them to deltamethrin and bendiocarb. Con-
trols consisted of specimens exposed to the insecticides
alone, and to PBO alone. The samples for the synergist
assays were 2–3 day old unfed, F1 females.
Laboratory analyses
Specimens were initially identified morphologically in
the field using the keys of Gillies and Coetzee [7]. DNA
was extracted from either legs or wings of individual
mosquitoes using a prepGEM insect DNA extraction kit
(ZyGEM, New Zealand) following the manufacturer’s in-
structions. Briefly, legs or wings of mosquitoes wereeles funestus that consistently results in >70% of the females
e used. Small pieces of filter paper are placed at an angle in the
, resting inside the plastic lids, can be transferred to clean vials once
Table 1 Identification of clades and P. falciparum infection rates by ELISA for An. funestus from Zimbabwe and Zambia
n Clades ELISA
I II Clade I Clade II Total
Zimbabwe 2013 342 92 (100%) - 7/303 (2.3%) - 7/303 (2.3%)
Zimbabwe 2014 140 88 (100%) - 4/115 (3.5%) - 4/115 (3.5%)
Zambia 2013 513 413 (80.5%) 100 (19.5%) 8/346 (2.3%) 1/76 (1.3%) 9/422 (2.1%)
Zambia 2014 332 264 (79.5%) 68 (20.5%) 17/171 (9.9%) 5/68 (7.4%) 22/239 (9.2%)
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75°C and then for 5 minutes at 95°C. A total of 10 μL of
solution from each sample was produced from the ex-
traction procedure. All specimens were identified to spe-
cies using the method of Koekemoer et al. [15]. After
PCR species identification, a subsample of An. funestus
was identified to clades using the hydrolysis probe ana-
lysis (Taqman assay) [21].
Plasmodium falciparum parasite infection in mosqui-
toes was detected from heads and thoraces of individual
females using the enzyme-linked immunosorbent assay
(ELISA) [22]. To validate the results, all of the positive
samples were re-analyzed with the ELISA after heating
the ELISA-homogenates in a heat block for 10 minutes
at 100°C [23]. A positive control (recombinant P. falcip-
arum) and seven negative controls (uninfected insectary
female An. funestus) were included. An Ascent Multis-
kan (RC vl. 5.0, Genesis version 3.03, Labsystems) plate-
reader was used for the analysis of data. The number of
specimens that remained positive after heating the lysate
was used to calculate the sporozoite rate.Data analysis
Resistance intensity assay data were compared using one-
way ANOVA (Statistix 8 -Talahasee, Fl, USA). Variations
in mortality between synergised and unsynergised samplesTable 2 Insecticide susceptibility tests of total An. funestus fro
Zimbabwe
%24 hr mortality (n) 2013 % 24 hr mortality
Deltamethrin 65.3 (49) 85.1 (94)
Lambda-cyhalothrin 24.1 (83) 3.7 (54)
Bendiocarb 70.1 (67) 73.1 (104)
Propoxur 77.4 (53) -
DDT 100 (55) 100 (123)
Dieldrin 100 (43) -
Malathion 100 (48) -
Fenitrothion 100 (56) -
Pirimiphos-methyl - 100 (104)
Controls 0 (82) 1.9 (104)were assessed using Chi-square (Statistix 8 -Talahasee, Fl,
USA).Results
Identification of An. funestus
All specimens were identified morphologically as be-
longing to the An. funestus group [7]. Table 1 presents
the results of molecular species confirmation and clade
identifications by year [15,21] of a total of 482 and 845
specimens of An. funestus from Zimbabwe and Zambia
respectively. The Taqman assay used for mtDNA clade
identification [21] revealed that only clade I was present in
Zimbabwe, although sample sizes were relatively small
and clade II might have been missed. In Zambia, 677 spec-
imens were identified as clade I (80%) and 168 as clade II
(20%). These proportions did not differ between 2013 and
2014 collections. A single specimen of An. leesoni was
identified by PCR.Enzyme-linked immunosorbent assays (ELISA)
The Plasmodium falciparum infection rates are given in
Table 1. A total of 725 female mosquitoes were tested
using the original ELISA method [22] with a second re-
analysis of positive specimens using the heated ELISA
lysate method [23] to confirm the results. In 2013, the
infection rates were 2.3% for clade I from both Zimbabwem Zimbabwe and Zambia for two consecutive years
Zambia
(n) 2014 %24 hr mortality (n) 2013 % 24 hr mortality (n) 2014
47.2 (72) 45.5 (99)
19.0 (79) -
75.5 (102) 45.2 (104)
60.5 (76) 79.3 (92)
100 (73) 100 (62)
100 (68) 100 (56)
100 (106) 99 (95)
100 (92) 100 (43)
- 100 (96)
0 (94) 4.8 (83)
Table 3 Status of insecticide resistance for the clades of
wild An. funestus females from Zambia in 2013









Deltamethrin 59 42.4 13 76.9
Lambda-cyhalothrin 60 18.3 19 21.0
Bendiocarb 83 77.5 19 73.7
Propoxur 67 57.6 9 77.3
Figure 3 Insecticide resistance intensity tests where susceptible
(FANG) and Zimbabwe resistant (FuZim-B) An. funestus were
exposed to 0.1% bendiocarb for 8 hours.
Choi et al. Parasites & Vectors 2014, 7:464 Page 5 of 8
http://www.parasitesandvectors.com/content/7/1/464and Zambia while the Zambian clade II samples had an
infection rate of 1.3%. In 2014, both localities showed an
increase in sporozoite rates with 3.5% in Zimbabwe, 9.9%
in Zambia clade I and 7.4% in clade II.
Insecticide resistance WHO bioassays
Insecticide resistance tests were carried out using the
standard WHO methods and diagnostic doses [18] for
two pyrethroids, two carbamates, two organochlorines
and three organophosphates. Anopheles funestus from
Zimbabwe and Zambia were all susceptible to the organ-
ochlorines and the organophosphates but resistant to py-
rethroids and carbamates (Table 2). Table 3 gives the
susceptibility results for the two clades in Zambia to py-
rethroids and carbamates but given that the sample sizes
are very small, these results require further investigation.
In all cases, An. funestus meets the WHO criteria for re-
sistance (i.e. <90% mortality) to both pyrethroids and
carbamates [18].
Resistance intensity experiments
The results are shown in Figures 2, 3, 4, 5, 6, 7 and
Table 4. Data points in Figures 2, 3, 4, 5, 6 and 7 are
overall percentage knock-downs across all replicates.
Both Zimbabwe clade I and Zambian clades I and II
showed similar results for 8-hr exposures to delta-
methrin that were significantly different to the FANGFigure 2 Insecticide resistance intensity tests where susceptible
(FANG) and Zimbabwe resistant An. funestus were exposed to
0.05% deltamethrin (FuZim-D) and lambda-cyhalothrin
(FuZim-L) for 8 hours.results (ANOVA: df = 1; P < 0.01 in all cases) (Figures 2,
4 and 5). There were sufficient numbers of Zimbabwe
F1s to carry out tests on lambda-cyhalothrin and the
results showed that there was no statistically signifi-
cant difference between the responses to this insecti-
cide compared with deltamethrin over the entire 8 hr
monitoring period (ANOVA: df = 1; F = 3.33; P = 0.08),
although the rate of knockdown induced by lambda-
cyhalothrin was significantly higher than that induced
by deltamethrin for the period 60 min to 8 hrs (ANOVA:
df = 1; F = 6.55; P = 0.02) (Figure 2).
Experiments carried out on bendiocarb showed no dif-
ference between either locality compared with each other
or with their corresponding susceptible FANG (ANOVA:
df = 1; P > 0.05 in all cases) (Figures 3, 6 and 7).
Synergist bioassays
These assays [20] were performed on 2–5 day old F1 pro-
geny from both Zambia and Zimbabwe using piperonyl
butoxide (PBO) as the synergist for P450 mono-oxygenaseFigure 4 Insecticide resistance intensity tests where susceptible
(FANG) and Zambia resistant clade I (ZamF-C1-D) An. funestus
were exposed to 0.05% deltamethrin for 8 hours.
Figure 5 Insecticide resistance intensity tests where susceptible
(FANG) and Zambia resistant clade II (ZamF-C2-D) An. funestus
were exposed to 0.05% deltamethrin for 8 hours.
Figure 7 Insecticide resistance intensity tests where susceptible
(FANG) and Zambia resistant clade II (ZamF-C2-B) An. funestus
were exposed to 0.1% bendiocarb for 8 hours.
Table 4 Resistance intensity assays of Anopheles funestus
females by insecticide and strain/clade
Insecticide Strain/clade N (replicates) Mean % knock-down
(SE) after 8 hrs
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bioassays. Pre-exposure to PBO completely nullified delta-
methrin resistance in all three samples/clades (Chi-square:
df = 2; X2 = 7.83; P = 0.02), and almost completely nulli-
fied bendiocarb resistance in all three samples/clades
(Chi-square: df = 2; X2 = 43.8; P < 0.01).
Discussion and conclusions
Our data show that An. funestus clade II is not confined
to southern Mozambique and Madagascar [16,17] and can
be found as far north as Nchelenge District in Zambia, be-
ing 2,000 km further north than the current distribution
of Chibuto in Mozambique [17]. We do not have data on
seasonal abundance of the two clades, so it is possible that
clade II also occurs in the Honde Valley, Zimbabwe, but
was not detected due to its very low frequency at both
times of collection. The frequency of clades I and II in
Nchelenge District remained stable over the two years of
sampling. Neither the insecticide resistance data nor the
sporozoite infection rates provided clear evidence that theFigure 6 Insecticide resistance intensity tests where susceptible
(FANG) and Zambia resistant clade I (ZamF-C1-B) An. funestus
were exposed to 0.1% bendiocarb for 8 hours.clades are anything other than a polymorphism in a single
panmictic population.
The Plasmodium falciparum infection rates for the
2013 Zimbabwe (2.3%) and Zambia (2.1%) populations
were similar overall, with no significant difference between
clade I (8/346 - 2.3%) and clade II (1/76 - 1.3%) (Pearson’s
chi-square = 0.34, P = 0.56). However, there was a 4-fold
increase in sporozoite rates in Nchelenge District in 2014,
corresponding with an increase in reported malaria cases
(ICEMR data, personal communication). A slight increase
was also seen in the 2014 Zimbabwe sample. Of the eight
households sampled almost every single inhabitant had
had at least one bout of malaria during the 2013–2014
summer. This recent increasing trend of infective (and re-
sistant) An. funestus being associated with increasedexposure
Deltamethrin FANG 179 (7) 100
FUZIM 192 (8) 56.9 (3.9)
ZAMF C1 124 (5) 80.9 (6.4)
ZAMF C2 156 (6) 67.2 (1.9)
Bendiocarb FANG 113 (5) 100
FUZIM 183 (9) 100
ZAMF C1 100 (4) 100
ZAMF C2 96 (4) 100
Lambda-cyhalothrin FANG 18 (1) 100
FUZIM 106 (4) 87.9 (3.1)
Mean percentage knock-downs after 8 hour exposures are shown with standard
errors (SE) in parentheses where appropriate. FANG = insecticide susceptible
laboratory strain; FUZIM = F1 progeny from wild-caught females from
Zimbabwe; ZAMF C1 = F1 progeny from wild-caught clade I females from
Zambia; ZAMF C2 = F1 progeny from wild-caught clade II females from
Zambia; N = sample size with number of replicates in parentheses.
Table 5 Synergist experiments on An. funestus clades I








Deltamethrin 44.0 (50) 19.2 (26) 29.6 (54)
Deltamethrin +
PBO
100 (97) 100 (84) 100 (67)
Bendiocarb 85.2 (57) 6.7 (45) 34.0 (47)
Bendiocarb +
PBO
100 (56) 84.1 (44) 84.8 (46)
Control PBO 5.1 (79) 3.8 (52) -
% mortality = percentage mortality 24-hr post-exposure. (n) = number of
mosquitoes exposed.
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tries, such as Tanzania [24], Kenya [25] and Senegal [26].
These studies underline the importance of An. funestus as
a major malaria vector that is sometimes underestimated
by researchers and control programmes in Africa.
At present, malaria vector control programmes in Africa
rely heavily on chemical methods, with long-lasting in-
secticide treated bed nets (LLINs) and indoor house spray-
ing with residual insecticides (IRS) being the most widely
implemented. However, the alarming increase in insecticide
resistance in the main malaria vectors to many of the insec-
ticides used in control, such as pyrethroids, carbamates and
DDT, poses a very serious concern [27,28]. The susceptibil-
ity tests clearly showed that both these An. funestus popula-
tions are highly resistant to pyrethroids and carbamates
while remaining susceptible to DDT and the organophos-
phates. The malaria vector control interventions at both lo-
calities include distribution of LLINs and in the Honde
Valley, the houses had been sprayed with lambda-cyhalothrin
in December 2013. Neither intervention had any apparent
impact on malaria transmission.
The so-called resistance intensity test carried out here
was not a standard method of measuring resistance.
While the CDC bottle bioassay method [29] recom-
mends that exposures be continued beyond the diagnos-
tic time in order to assess resistance intensity, they
recommend that experiments be terminated at 2 hours
and the manual [29] does not give criteria for evaluating
resistance intensity. At the 2-hr interval, both An. funestus
populations showed mortality of less than 20% on the
WHO diagnostic dose of 0.05% deltamethrin indicating an
extremely high level of resistance. What this means in the
field, however, is difficult to judge since these tests do not
take into account repellent effects or whether an individ-
ual mosquito will indeed rest continuously for 8 hours, or
even 1 hour on a treated surface. What is clear however, is
that pyrethroid-resistant An. funestus is quite capable of
withstanding prolonged exposure to the pyrethroids used
for treating bed nets and for house spraying.The problem of insecticide resistance in An. funestus is
no longer a localized one. The resistant population first
detected in South Africa [30] and southern Mozambique
[20] has now spread to northern Malawi [31] and is affect-
ing the region as a whole, including the localities sampled
in this study. The evidence that we have indicates that the
resistance mechanisms are mediated by metabolic mono-
oxygenase enzymes, well documented in other An. funes-
tus populations [1]. This metabolic system does not incur
a fitness cost [32] and even in the absence of insecticide
pressure, the resistance is not lost, facilitating the geo-
graphical spread of resistance alleles. However, the resist-
ance in An. funestus populations is by no means uniform
across southern Africa with recent studies in south-
eastern Zambia showing resistance to DDT as well as py-
rethroids and carbamates [33].
This places yet more constraints on the vector con-
trol programmes operating in the region with only the
organophosphates having a generalised killing effect on
the An. funestus populations. While both Zambia and
Zimbabwe are changing their IRS policies and will be
using an organophosphate for IRS in the coming trans-
mission season, the need for additional, affordable, new
tools for vector control [28] has acquired an urgency as
never before.
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